Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

The role of funding and policies on innovation in cancer drug development

Share :
Published: 3 Feb 2010
Views: 10056
Rating:
Save
Prof Richard Sullivan - European Cancer Research Managers Forum

Professor Richard Sullivan, Chairman of the European Cancer Research Managers Forum, discusses the study he co-authored, reviewing innovation in cancer drug development. To read the paper click here.

Related Videos

Blood test may identify patients with non-small cell lung cancer subtype who...
Dr Pasi A. Jänne - Dana-Farber Cancer Institute, Boston, USA
Blood test may identify patients with non-small cell lung cancer subtype who can benefit from combination therapy ( Dr Pasi A. Jänne - Dana-Farber Cancer Institute, Boston, USA )
12 Apr 2024
Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial...
Dr Rebecca Porter - Dana-Farber Cancer Institute, Boston, USA
Mirvetuximab soravtansine and pembrolizumab combo shows promise in endometrial cancer subtype ( Dr Rebecca Porter - Dana-Farber Cancer Institute, Boston, USA )
12 Apr 2024
EAU 2024: Bladder cancer latest
Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea...
EAU 2024: Bladder cancer latest ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio )
9 Apr 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )
25 Mar 2024
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )
25 Mar 2024
Optimising multiple myeloma care in Latin America
Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico
Optimising multiple myeloma care in Latin America ( Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico )
6 Mar 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )
22 Feb 2024
ASCO GU 2024: Current best practice for mRCC
Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu
ASCO GU 2024: Current best practice for mRCC ( Prof Jens Bedke, Prof Thomas Powles, Prof Michael Staehler and Dr Wenxin Xu )
1 Feb 2024
Updates on lung cancer from WCLC and ESMO 2023
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
Updates on lung cancer from WCLC and ESMO 2023 ( Dr Luis Raez - Memorial Cancer Institute, Miami, USA )
31 Jan 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation